BIB Among An Index ETFs
End-of-day Nov 20, 2026 · 43 An index ETFs by 10Y
| Returns | Today | 1W | 1M | 3M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| Total return | −3.6% | −11.9% | −9.3% | −15.3% | +28.3% | +34.3% | +142.3% | +22.7% | +119.9% | +1,301.6% |
| Peer average | −11.7% | −24.1% | −32.4% | −41.4% | −22.5% | −19.6% | +46.2% | +13.5% | +215.8% | — |
| S&P 500 · VOO | −3.4% | −8.3% | −9.5% | −9.2% | +2.2% | +5.5% | +59.8% | +58.7% | +275.8% | — |
$182 of every $1,000 in BIB is Proshares
| # | ||||||
|---|---|---|---|---|---|---|
| 1 | IQMMProshares Genius MNY MKT ETF | Financial Services | 18.20% | $1,819.76 | 170K | $17.0M |
| 2 | —Net Other Assets (Liabilities) | — | 15.55% | $1,555.02 | 14.5M | $14.5M |
| 3 | GILDGilead Sciences | Healthcare | 6.24% | $624.18 | 35K | $5.8M |
| 4 | AMGNAmgen | Healthcare | 5.57% | $556.71 | 12K | $5.2M |
| 5 | VRTXVertex Pharmaceuticals | Healthcare | 5.24% | $524.43 | 9,419 | $4.9M |
| 6 | REGNRegeneron Pharmaceuticals | Healthcare | 4.19% | $418.82 | 4,246 | $3.9M |
| 7 | MRNAModerna | Healthcare | 3.57% | $357.30 | 17K | $3.3M |
| 8 | BIIBBiogen | Healthcare | 1.64% | $163.96 | 6,204 | $1.5M |
| 9 | RVMDRevolution Medicines | Healthcare | 1.53% | $153.42 | 8,999 | $1.4M |
| 10 | INSMInsmed | Healthcare | 1.42% | $141.63 | 9,168 | $1.3M |
| 11 | ILMNIllumina | Healthcare | 1.36% | $136.04 | 6,340 | $1.3M |
| 12 | RPRXRoyalty Pharma | Healthcare | 1.35% | $135.38 | 19K | $1.3M |
| 13 | ROIVRoivant Sciences | Healthcare | 1.26% | $126.35 | 30K | $1.2M |
| 14 | ARGXArgenx SE | Healthcare | 1.15% | $115.45 | 1,146 | $1.1M |
| 15 | UTHRUnited Therapeutics | Healthcare | 1.08% | $107.74 | 1,802 | $1.0M |
of the $103B in 406 An index ETFs
| # | Ticker | Company | Weight ▼ |
|---|---|---|---|
| 1 | IQMM | Proshares Genius MNY MKT ETF | 18.20% |
| 2 | GILD | Gilead Sciences | 6.24% |
| 3 | AMGN | Amgen | 5.57% |
| 4 | VRTX | Vertex Pharmaceuticals | 5.24% |
| 5 | REGN | Regeneron Pharmaceuticals | 4.19% |
| 6 | MRNA | Moderna | 3.57% |
| 7 | BIIB | Biogen | 1.64% |
| 8 | RVMD | Revolution Medicines | 1.53% |
| 9 | INSM | Insmed | 1.42% |
| 10 | ILMN | Illumina | 1.36% |
Estimated yearly cost excludes trading costs and assumes constant assets.
| Ex-date | Paid | Per share |
|---|---|---|
| Sep 23, 2026 | Sep 29, 2026 | $0.0413 |
| Mar 25, 2026 | Mar 31, 2026 | $0.0036 |
| Dec 24, 2025 | Dec 31, 2025 | $0.0673 |
| Sep 24, 2025 | Sep 30, 2025 | $0.0903 |
| Jun 25, 2025 | Jul 1, 2025 | $0.0853 |
| Mar 26, 2025 | Apr 1, 2025 | $0.0655 |
| Dec 23, 2024 | Dec 31, 2024 | $0.20 |
| Sep 25, 2024 | Oct 2, 2024 | $0.0764 |
| Jun 26, 2024 | Jul 3, 2024 | $0.13 |
| Mar 20, 2024 | Mar 27, 2024 | $0.0202 |
| Dec 20, 2023 | Dec 28, 2023 | $0.0192 |
| Dec 22, 2022 | Dec 30, 2022 | $0.0099 |